カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のオフボディ型ウェアラブルインジェクター市場2022年：電子インジェクター、機械式インジェクター、その他

◆英語タイトル：Global Off-body Wearable Injectors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8227 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：115 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

オフボディ型ウェアラブルインジェクター市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のオフボディ型ウェアラブルインジェクターの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

オフボディ型ウェアラブルインジェクター市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・電子インジェクター、機械式インジェクター、その他

用途別セグメントは次のように区分されます。
・免疫腫瘍、糖尿病、心血管疾患、その他

世界のオフボディ型ウェアラブルインジェクター市場の主要な市場プレーヤーは以下のとおりです。
・Becton, Dickinson and Company、Medtronic、Johnson & Johnson、Insulet Corporation、Unilife Corporation、Enable Injections、SteadyMed、Ypsomed Group、West Pharmaceutical Services、Unilife、CeQur、Sensile Medical、Roche、ScPharmaceuticals、SteadyMed

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、オフボディ型ウェアラブルインジェクター製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なオフボディ型ウェアラブルインジェクターメーカーの企業概要、2019年～2022年までのオフボディ型ウェアラブルインジェクターの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なオフボディ型ウェアラブルインジェクターメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別オフボディ型ウェアラブルインジェクターの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのオフボディ型ウェアラブルインジェクターの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのオフボディ型ウェアラブルインジェクター市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびオフボディ型ウェアラブルインジェクターの産業チェーンを掲載しています。
・第13、14、15章では、オフボディ型ウェアラブルインジェクターの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Becton, Dickinson and Company、Medtronic、Johnson & Johnson、Insulet Corporation、Unilife Corporation、Enable Injections、SteadyMed、Ypsomed Group、West Pharmaceutical Services、Unilife、CeQur、Sensile Medical、Roche、ScPharmaceuticals、SteadyMed
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：電子インジェクター、機械式インジェクター、その他
・用途別分析2017年-2028年：免疫腫瘍、糖尿病、心血管疾患、その他
・オフボディ型ウェアラブルインジェクターの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・オフボディ型ウェアラブルインジェクターのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・オフボディ型ウェアラブルインジェクターのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・オフボディ型ウェアラブルインジェクターの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・オフボディ型ウェアラブルインジェクターの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Off-body Wearable Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Off-body Wearable Injectors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immuno-oncology accounting for % of the Off-body Wearable Injectors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Electronical Injectors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Off-body Wearable Injectors include Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, and Unilife Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Off-body Wearable Injectors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Electronical Injectors
Mechanical Injectors
Others
Market segment by Application can be divided into
Immuno-oncology
Diabetes
Cardiovascular Diseases
Other
The key market players for global Off-body Wearable Injectors market are listed below:
Becton, Dickinson and Company
Medtronic
Johnson & Johnson
Insulet Corporation
Unilife Corporation
Enable Injections
SteadyMed
Ypsomed Group
West Pharmaceutical Services
Unilife
CeQur
Sensile Medical
Roche
ScPharmaceuticals
SteadyMed
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Off-body Wearable Injectors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Off-body Wearable Injectors, with price, sales, revenue and global market share of Off-body Wearable Injectors from 2019 to 2022.
Chapter 3, the Off-body Wearable Injectors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Off-body Wearable Injectors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Off-body Wearable Injectors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Off-body Wearable Injectors.
Chapter 13, 14, and 15, to describe Off-body Wearable Injectors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Off-body Wearable Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Off-body Wearable Injectors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Off-body Wearable Injectors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Global Off-body Wearable Injectors Market Size & Forecast
1.4.1 Global Off-body Wearable Injectors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Off-body Wearable Injectors Sales in Volume (2017-2028)
1.4.3 Global Off-body Wearable Injectors Price (2017-2028)
1.5 Global Off-body Wearable Injectors Production Capacity Analysis
1.5.1 Global Off-body Wearable Injectors Total Production Capacity (2017-2028)
1.5.2 Global Off-body Wearable Injectors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Off-body Wearable Injectors Market Drivers
1.6.2 Off-body Wearable Injectors Market Restraints
1.6.3 Off-body Wearable Injectors Trends Analysis
2 Manufacturers Profiles
2.1 Becton, Dickinson and Company
2.1.1 Becton, Dickinson and Company Details
2.1.2 Becton, Dickinson and Company Major Business
2.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Product and Services
2.1.4 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Off-body Wearable Injectors Product and Services
2.2.4 Medtronic Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Off-body Wearable Injectors Product and Services
2.3.4 Johnson & Johnson Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Insulet Corporation
2.4.1 Insulet Corporation Details
2.4.2 Insulet Corporation Major Business
2.4.3 Insulet Corporation Off-body Wearable Injectors Product and Services
2.4.4 Insulet Corporation Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Unilife Corporation
2.5.1 Unilife Corporation Details
2.5.2 Unilife Corporation Major Business
2.5.3 Unilife Corporation Off-body Wearable Injectors Product and Services
2.5.4 Unilife Corporation Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Enable Injections
2.6.1 Enable Injections Details
2.6.2 Enable Injections Major Business
2.6.3 Enable Injections Off-body Wearable Injectors Product and Services
2.6.4 Enable Injections Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 SteadyMed
2.7.1 SteadyMed Details
2.7.2 SteadyMed Major Business
2.7.3 SteadyMed Off-body Wearable Injectors Product and Services
2.7.4 SteadyMed Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ypsomed Group
2.8.1 Ypsomed Group Details
2.8.2 Ypsomed Group Major Business
2.8.3 Ypsomed Group Off-body Wearable Injectors Product and Services
2.8.4 Ypsomed Group Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 West Pharmaceutical Services
2.9.1 West Pharmaceutical Services Details
2.9.2 West Pharmaceutical Services Major Business
2.9.3 West Pharmaceutical Services Off-body Wearable Injectors Product and Services
2.9.4 West Pharmaceutical Services Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Unilife
2.10.1 Unilife Details
2.10.2 Unilife Major Business
2.10.3 Unilife Off-body Wearable Injectors Product and Services
2.10.4 Unilife Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 CeQur
2.11.1 CeQur Details
2.11.2 CeQur Major Business
2.11.3 CeQur Off-body Wearable Injectors Product and Services
2.11.4 CeQur Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sensile Medical
2.12.1 Sensile Medical Details
2.12.2 Sensile Medical Major Business
2.12.3 Sensile Medical Off-body Wearable Injectors Product and Services
2.12.4 Sensile Medical Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Roche
2.13.1 Roche Details
2.13.2 Roche Major Business
2.13.3 Roche Off-body Wearable Injectors Product and Services
2.13.4 Roche Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 ScPharmaceuticals
2.14.1 ScPharmaceuticals Details
2.14.2 ScPharmaceuticals Major Business
2.14.3 ScPharmaceuticals Off-body Wearable Injectors Product and Services
2.14.4 ScPharmaceuticals Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 SteadyMed
2.15.1 SteadyMed Details
2.15.2 SteadyMed Major Business
2.15.3 SteadyMed Off-body Wearable Injectors Product and Services
2.15.4 SteadyMed Off-body Wearable Injectors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Off-body Wearable Injectors Breakdown Data by Manufacturer
3.1 Global Off-body Wearable Injectors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Off-body Wearable Injectors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Off-body Wearable Injectors
3.4 Market Concentration Rate
3.4.1 Top 3 Off-body Wearable Injectors Manufacturer Market Share in 2021
3.4.2 Top 6 Off-body Wearable Injectors Manufacturer Market Share in 2021
3.5 Global Off-body Wearable Injectors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Off-body Wearable Injectors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Off-body Wearable Injectors Market Size by Region
4.1.1 Global Off-body Wearable Injectors Sales in Volume by Region (2017-2028)
4.1.2 Global Off-body Wearable Injectors Revenue by Region (2017-2028)
4.2 North America Off-body Wearable Injectors Revenue (2017-2028)
4.3 Europe Off-body Wearable Injectors Revenue (2017-2028)
4.4 Asia-Pacific Off-body Wearable Injectors Revenue (2017-2028)
4.5 South America Off-body Wearable Injectors Revenue (2017-2028)
4.6 Middle East and Africa Off-body Wearable Injectors Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Off-body Wearable Injectors Sales in Volume by Type (2017-2028)
5.2 Global Off-body Wearable Injectors Revenue by Type (2017-2028)
5.3 Global Off-body Wearable Injectors Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Off-body Wearable Injectors Sales in Volume by Application (2017-2028)
6.2 Global Off-body Wearable Injectors Revenue by Application (2017-2028)
6.3 Global Off-body Wearable Injectors Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Off-body Wearable Injectors Sales by Type (2017-2028)
7.2 North America Off-body Wearable Injectors Sales by Application (2017-2028)
7.3 North America Off-body Wearable Injectors Market Size by Country
7.3.1 North America Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
7.3.2 North America Off-body Wearable Injectors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Off-body Wearable Injectors Sales by Type (2017-2028)
8.2 Europe Off-body Wearable Injectors Sales by Application (2017-2028)
8.3 Europe Off-body Wearable Injectors Market Size by Country
8.3.1 Europe Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
8.3.2 Europe Off-body Wearable Injectors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Off-body Wearable Injectors Sales by Type (2017-2028)
9.2 Asia-Pacific Off-body Wearable Injectors Sales by Application (2017-2028)
9.3 Asia-Pacific Off-body Wearable Injectors Market Size by Region
9.3.1 Asia-Pacific Off-body Wearable Injectors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Off-body Wearable Injectors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Off-body Wearable Injectors Sales by Type (2017-2028)
10.2 South America Off-body Wearable Injectors Sales by Application (2017-2028)
10.3 South America Off-body Wearable Injectors Market Size by Country
10.3.1 South America Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
10.3.2 South America Off-body Wearable Injectors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Off-body Wearable Injectors Sales by Type (2017-2028)
11.2 Middle East & Africa Off-body Wearable Injectors Sales by Application (2017-2028)
11.3 Middle East & Africa Off-body Wearable Injectors Market Size by Country
11.3.1 Middle East & Africa Off-body Wearable Injectors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Off-body Wearable Injectors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Off-body Wearable Injectors and Key Manufacturers
12.2 Manufacturing Costs Percentage of Off-body Wearable Injectors
12.3 Off-body Wearable Injectors Production Process
12.4 Off-body Wearable Injectors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Off-body Wearable Injectors Typical Distributors
13.3 Off-body Wearable Injectors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Off-body Wearable Injectors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Off-body Wearable Injectors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 4. Becton, Dickinson and Company Major Business
Table 5. Becton, Dickinson and Company Off-body Wearable Injectors Product and Services
Table 6. Becton, Dickinson and Company Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Medtronic Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Major Business
Table 9. Medtronic Off-body Wearable Injectors Product and Services
Table 10. Medtronic Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 12. Johnson & Johnson Major Business
Table 13. Johnson & Johnson Off-body Wearable Injectors Product and Services
Table 14. Johnson & Johnson Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Insulet Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Insulet Corporation Major Business
Table 17. Insulet Corporation Off-body Wearable Injectors Product and Services
Table 18. Insulet Corporation Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Unilife Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Unilife Corporation Major Business
Table 21. Unilife Corporation Off-body Wearable Injectors Product and Services
Table 22. Unilife Corporation Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 24. Enable Injections Major Business
Table 25. Enable Injections Off-body Wearable Injectors Product and Services
Table 26. Enable Injections Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. SteadyMed Basic Information, Manufacturing Base and Competitors
Table 28. SteadyMed Major Business
Table 29. SteadyMed Off-body Wearable Injectors Product and Services
Table 30. SteadyMed Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ypsomed Group Basic Information, Manufacturing Base and Competitors
Table 32. Ypsomed Group Major Business
Table 33. Ypsomed Group Off-body Wearable Injectors Product and Services
Table 34. Ypsomed Group Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
Table 36. West Pharmaceutical Services Major Business
Table 37. West Pharmaceutical Services Off-body Wearable Injectors Product and Services
Table 38. West Pharmaceutical Services Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Unilife Basic Information, Manufacturing Base and Competitors
Table 40. Unilife Major Business
Table 41. Unilife Off-body Wearable Injectors Product and Services
Table 42. Unilife Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. CeQur Basic Information, Manufacturing Base and Competitors
Table 44. CeQur Major Business
Table 45. CeQur Off-body Wearable Injectors Product and Services
Table 46. CeQur Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Sensile Medical Basic Information, Manufacturing Base and Competitors
Table 48. Sensile Medical Major Business
Table 49. Sensile Medical Off-body Wearable Injectors Product and Services
Table 50. Sensile Medical Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Roche Basic Information, Manufacturing Base and Competitors
Table 52. Roche Major Business
Table 53. Roche Off-body Wearable Injectors Product and Services
Table 54. Roche Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. ScPharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. ScPharmaceuticals Major Business
Table 57. ScPharmaceuticals Off-body Wearable Injectors Product and Services
Table 58. ScPharmaceuticals Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. SteadyMed Basic Information, Manufacturing Base and Competitors
Table 60. SteadyMed Major Business
Table 61. SteadyMed Off-body Wearable Injectors Product and Services
Table 62. SteadyMed Off-body Wearable Injectors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Off-body Wearable Injectors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 64. Global Off-body Wearable Injectors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Off-body Wearable Injectors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Off-body Wearable Injectors Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Off-body Wearable Injectors Production Site of Key Manufacturer
Table 68. Off-body Wearable Injectors New Entrant and Capacity Expansion Plans
Table 69. Off-body Wearable Injectors Mergers & Acquisitions in the Past Five Years
Table 70. Global Off-body Wearable Injectors Sales by Region (2017-2022) & (K Units)
Table 71. Global Off-body Wearable Injectors Sales by Region (2023-2028) & (K Units)
Table 72. Global Off-body Wearable Injectors Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Off-body Wearable Injectors Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 75. Global Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 76. Global Off-body Wearable Injectors Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Off-body Wearable Injectors Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Off-body Wearable Injectors Price by Type (2017-2022) & (US$/Unit)
Table 79. Global Off-body Wearable Injectors Price by Type (2023-2028) & (US$/Unit)
Table 80. Global Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 81. Global Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 82. Global Off-body Wearable Injectors Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Off-body Wearable Injectors Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Off-body Wearable Injectors Price by Application (2017-2022) & (US$/Unit)
Table 85. Global Off-body Wearable Injectors Price by Application (2023-2028) & (US$/Unit)
Table 86. North America Off-body Wearable Injectors Sales by Country (2017-2022) & (K Units)
Table 87. North America Off-body Wearable Injectors Sales by Country (2023-2028) & (K Units)
Table 88. North America Off-body Wearable Injectors Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Off-body Wearable Injectors Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 91. North America Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 92. North America Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 93. North America Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 94. Europe Off-body Wearable Injectors Sales by Country (2017-2022) & (K Units)
Table 95. Europe Off-body Wearable Injectors Sales by Country (2023-2028) & (K Units)
Table 96. Europe Off-body Wearable Injectors Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Off-body Wearable Injectors Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 99. Europe Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 100. Europe Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 101. Europe Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 102. Asia-Pacific Off-body Wearable Injectors Sales by Region (2017-2022) & (K Units)
Table 103. Asia-Pacific Off-body Wearable Injectors Sales by Region (2023-2028) & (K Units)
Table 104. Asia-Pacific Off-body Wearable Injectors Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Off-body Wearable Injectors Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 107. Asia-Pacific Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 108. Asia-Pacific Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 109. Asia-Pacific Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 110. South America Off-body Wearable Injectors Sales by Country (2017-2022) & (K Units)
Table 111. South America Off-body Wearable Injectors Sales by Country (2023-2028) & (K Units)
Table 112. South America Off-body Wearable Injectors Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Off-body Wearable Injectors Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 115. South America Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 116. South America Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 117. South America Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 118. Middle East & Africa Off-body Wearable Injectors Sales by Region (2017-2022) & (K Units)
Table 119. Middle East & Africa Off-body Wearable Injectors Sales by Region (2023-2028) & (K Units)
Table 120. Middle East & Africa Off-body Wearable Injectors Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Off-body Wearable Injectors Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Off-body Wearable Injectors Sales by Type (2017-2022) & (K Units)
Table 123. Middle East & Africa Off-body Wearable Injectors Sales by Type (2023-2028) & (K Units)
Table 124. Middle East & Africa Off-body Wearable Injectors Sales by Application (2017-2022) & (K Units)
Table 125. Middle East & Africa Off-body Wearable Injectors Sales by Application (2023-2028) & (K Units)
Table 126. Off-body Wearable Injectors Raw Material
Table 127. Key Manufacturers of Off-body Wearable Injectors Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Off-body Wearable Injectors Typical Distributors
Table 131. Off-body Wearable Injectors Typical Customers
List of Figures
Figure 1. Off-body Wearable Injectors Picture
Figure 2. Global Off-body Wearable Injectors Revenue Market Share by Type in 2021
Figure 3. Electronical Injectors
Figure 4. Mechanical Injectors
Figure 5. Others
Figure 6. Global Off-body Wearable Injectors Revenue Market Share by Application in 2021
Figure 7. Immuno-oncology
Figure 8. Diabetes
Figure 9. Cardiovascular Diseases
Figure 10. Other
Figure 11. Global Off-body Wearable Injectors Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Off-body Wearable Injectors Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Off-body Wearable Injectors Sales (2017-2028) & (K Units)
Figure 14. Global Off-body Wearable Injectors Price (2017-2028) & (US$/Unit)
Figure 15. Global Off-body Wearable Injectors Production Capacity (2017-2028) & (K Units)
Figure 16. Global Off-body Wearable Injectors Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Off-body Wearable Injectors Market Drivers
Figure 18. Off-body Wearable Injectors Market Restraints
Figure 19. Off-body Wearable Injectors Market Trends
Figure 20. Global Off-body Wearable Injectors Sales Market Share by Manufacturer in 2021
Figure 21. Global Off-body Wearable Injectors Revenue Market Share by Manufacturer in 2021
Figure 22. Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Off-body Wearable Injectors Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Off-body Wearable Injectors Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Off-body Wearable Injectors Sales Market Share by Region (2017-2028)
Figure 26. Global Off-body Wearable Injectors Revenue Market Share by Region (2017-2028)
Figure 27. North America Off-body Wearable Injectors Revenue (2017-2028) & (USD Million)
Figure 28. Europe Off-body Wearable Injectors Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Off-body Wearable Injectors Revenue (2017-2028) & (USD Million)
Figure 30. South America Off-body Wearable Injectors Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Off-body Wearable Injectors Revenue (2017-2028) & (USD Million)
Figure 32. Global Off-body Wearable Injectors Sales Market Share by Type (2017-2028)
Figure 33. Global Off-body Wearable Injectors Revenue Market Share by Type (2017-2028)
Figure 34. Global Off-body Wearable Injectors Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 36. Global Off-body Wearable Injectors Revenue Market Share by Application (2017-2028)
Figure 37. Global Off-body Wearable Injectors Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Off-body Wearable Injectors Sales Market Share by Type (2017-2028)
Figure 39. North America Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 40. North America Off-body Wearable Injectors Sales Market Share by Country (2017-2028)
Figure 41. North America Off-body Wearable Injectors Revenue Market Share by Country (2017-2028)
Figure 42. United States Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Off-body Wearable Injectors Sales Market Share by Type (2017-2028)
Figure 46. Europe Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 47. Europe Off-body Wearable Injectors Sales Market Share by Country (2017-2028)
Figure 48. Europe Off-body Wearable Injectors Revenue Market Share by Country (2017-2028)
Figure 49. Germany Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Off-body Wearable Injectors Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Off-body Wearable Injectors Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Off-body Wearable Injectors Revenue Market Share by Region (2017-2028)
Figure 58. China Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Off-body Wearable Injectors Sales Market Share by Type (2017-2028)
Figure 65. South America Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 66. South America Off-body Wearable Injectors Sales Market Share by Country (2017-2028)
Figure 67. South America Off-body Wearable Injectors Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Off-body Wearable Injectors Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Off-body Wearable Injectors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Off-body Wearable Injectors in 2021
Figure 79. Manufacturing Process Analysis of Off-body Wearable Injectors
Figure 80. Off-body Wearable Injectors Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオフボディ型ウェアラブルインジェクター市場2022年：電子インジェクター、機械式インジェクター、その他(Global Off-body Wearable Injectors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のオフボディ型ウェアラブルインジェクター市場2022年：電子インジェクター、機械式インジェクター、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp